Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancer
- 1 July 1999
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 56 (2) , 111-122
- https://doi.org/10.1023/a:1006221425652
Abstract
The effectiveness of combining mitomycin C (MMC), tamoxifen (TAM), and 1-(2-tetrahydrofuryl)-5-fluorouracil (tegafur) was evident in patients with estrogen receptor-positive (ER+) breast cancers....Keywords
This publication has 21 references indexed in Scilit:
- Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of JapanEuropean Journal Of Cancer, 1996
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Estrogen-Receptor-Negative Breast Cancer Tissue Is Chemosensitive in vitro Compared with Estrogen-Receptor-Positive TissueEuropean Surgical Research, 1990
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Adjuvant Chemotherapy for Breast CancerPublished by American Medical Association (AMA) ,1985
- The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancerBreast Cancer Research and Treatment, 1982
- The cancer research campaign (King's/Cambridge trial for early breast cancer: Clinico-pathological aspectsBritish Journal of Cancer, 1982
- Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancerCancer, 1980
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978